SPP1 and cancer: Previous studies have proven that SPP1 is overexpressed in a variety of cancers and can be used to predict the adverse consequences, including ovarian cancer (Zeng et al. (2018)), glioblastoma (Kijewska et al. (2017)), hepatocellular carcinoma (Wang et al. (2019)), and gastric cancer (Song et al. (2019)).